PAREXEL International Corp (prxl.o)

+ 收藏

公司介绍(PAREXEL International Corp)

证券代码 PRXL.O
证券名称 PAREXEL International Corp
证券类型 美股
上市场所 纳斯达克交易所
上市板块 -
发行方式 -
首发上市日 1995-11-22
首发价格(元) -
首发数量(股) 0
首发募资额(元) -
首发主承销商 -
货币单位 USD
公司名称 PAREXEL International Corporation
注册地址 美国马萨诸塞州
办公地址 195 West Street, Waltham, Massachusetts, USA
成立日期 1983
董事会主席 Josef H. von Rickenbach
公司属地 United States 美国
公司网址 www.parexel.com
电话 +1 (781) 487-9900
传真 -
公司简介 PAREXEL International Corporation is a leading biopharmaceutical outsourcing services company, providing a broad range of expertise in clinical research, clinical logistics, medical communications, consulting, commercialization and advanced technology products and services to the worldwide pharmaceutical, biotechnology, and medical device industries. Its primary objective is to provide quality solutions for managing the biopharmaceutical product lifecycle with the goal of reducing the time, risk, and cost associated with the development and commercialization of new therapies. Since its incorporation in 1983, it has developed significant expertise in processes and technologies supporting this strategy. Its product and service offerings include: clinical trials management, observational studies and patient/disease registries, data management, biostatistical analysis, epidemiology, health economics/outcomes research, pharmacovigilance, medical communications, clinical pharmacology, patient recruitment, clinical supply and drug logistics, post-marketing surveillance, regulatory and product development and commercialization consulting, health policy and reimbursement and market access consulting, medical imaging services, regulatory information management (“RIM”) solutions, randomization and trial supply management services (“RTSM”), electronic data capture systems (“EDC”), clinical trial management systems (“CTMS”), web-based portals, systems integration, patient diary applications, and other product development tools and services.

前瞻产业研究院